Logo
x

Search

Subscribe Now

P-l

reMYND Commences P-l Study of RES19-T for Alzheimer's Disease

reMYND Commences P-l Study of RES19-T for Alzheimer's Disease

  • December 4, 2020
AstraZeneca to Unveil its Robust Pipeline of Breast Cancer at SABCS

AstraZeneca to Unveil its Robust Pipeline of Breast Cancer at SABCS

  • December 3, 2020
Lilly Reports Results of Tirzepatide in P-lll SURPASS-2 Trial for Type-2 Diabetes

    Lilly Reports Results of Tirzepatide in P-lll SURPASS-2 Trial for Type-2 Diabetes

    • March 5, 2021
    Lilly Reports Results of Tirzepatide in P-lll SURPASS-3 and 5 Trials for Type-2 Diabetes

      Lilly Reports Results of Tirzepatide in P-lll SURPASS-3 and 5 Trials for Type-2 Diabetes

      • February 18, 2021
      aTyr Reports Results of ATYR1923 in P-ll Study for COVID-19 Patients with Severe Respiratory Complications

        aTyr Reports Results of ATYR1923 in P-ll Study for COVID-19 Patients with Severe Respiratory Complications

        • January 5, 2021
        Sinopharm

          Sinopharm's COVID-19 Vaccine Demonstrates 79% Efficacy in P-III Study

          • December 31, 2020
          Novo Nordisk to Initiate a P-lll Study of Semaglutide to Treat Alzheimer Disease

            Novo Nordisk to Initiate a P-lll Study of Semaglutide to Treat Alzheimer Disease

            • December 17, 2020
            CureVac Commences P-llb/lll Trial of CVnCoV for COVID-19

              CureVac Commences P-llb/lll Trial of CVnCoV for COVID-19

              • December 15, 2020
              Image

              Incisive News in 3 Shots.

              Contact Us

              Our Information

              Follow Us

              Copyright © 2025 PharmaShots - All Rights Reserved.